Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06483373
EARLY_PHASE1

A Clinical Study of SPH7854 Granules in Healthy Subjects.

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd

View on ClinicalTrials.gov

Summary

To evaluate the safety of SPH7854 in healthy subjects.

Official title: A Single and Multiple Dose-escalation, and Food Effects of Phase I Clinical Study to Evaluate the Tolerability/Safety/Pharmacokinetics of SPH7854 Granules in Healthy Subjects.

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

111

Start Date

2024-05-28

Completion Date

2025-12-31

Last Updated

2025-08-17

Healthy Volunteers

Yes

Interventions

DRUG

SPH7854

SPH7854: Orally, 50-3200mg

DRUG

Placebo

Placebo:Orally;

Locations (1)

West China Second University Hospital, Sichuan University

Chengdu, China